As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...

Actress and talk show host Busy Philipps as well as sports reporter Jay Glazer have both headed up separate campaigns for Qelbree, a non-stimulant ADHD treatment manufactured by Supernus. This marks a ...

Following its acquisition by Supernus Pharmaceuticals, Sage Therapeutics has let go of all of its remaining workforce, which ...

DELAWARE, DE, UNITED STATES, July 4, 2025 /EINPresswire.com/ -- The global Attention Deficit Hyperactivity Disorder (ADHD) market is anticipated to reach USD 18.3 billion by 2025, as a result of ...

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of ...

DelveInsight's Parkinson's Disease Pipeline report depicts a robust space with 130+ active players working to develop 150+ ...

Sage Therapeutics, Inc. (NASDAQ: SAGE) related to its sale to Supernus Pharmaceuticals, Inc. Upon completion of the proposed ...